Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/4373
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Serwaa, D. | - |
dc.contributor.author | Osei-Boakye, F. | - |
dc.contributor.author | Nkansah, C. | - |
dc.contributor.author | Ahiatrogah, S. | - |
dc.contributor.author | Lamptey, E. | - |
dc.contributor.author | Abdulai, R. | - |
dc.contributor.author | Antwi, M. H. | - |
dc.contributor.author | Wirekohh, E. Y. | - |
dc.contributor.author | Owusui, E. | - |
dc.contributor.author | Buckman, T. A. | - |
dc.contributor.author | Danquah, M. | - |
dc.date.accessioned | 2025-02-10T12:12:30Z | - |
dc.date.available | 2025-02-10T12:12:30Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 2164-554X | - |
dc.identifier.uri | http://hdl.handle.net/123456789/4373 | - |
dc.description.abstract | Health-care professionals in Ghana were among the prioritized high-risk groups to be administered with the initial supply of Oxford/AstraZeneca vaccine procured by the Government of Ghana. This study sought to assess and identify the determinants of COVID-19 vaccine short-term side effects among health-care workers. A cross-sectional study was conducted on 654 Ghanaian healthcare workers between 16th March and 5th May 2021. The study included health-care workers in registered health settings, who had been vaccinated against COVID-19 and consented to participate in the survey. Descriptive statistics, binary and multivariable logistic regression analyses were executed using SPSS version 22 at p < .05. The findings revealed that, 528 (80.7%) of the participants experienced adverse reactions, which lasted between 0 and 2 days among, 347 (53.1%) of the study participants. The most reported adverse reactions were general body weakness, 434 (32.0%), headache 371 (27.3%), and fever, 257 (19.1%). Health workers aged 35–39 and 40–44 years had lower odds of adverse reactions compared with those aged 25–29 years (aOR: 0.34, 95% C.I. 0.186,0.621, p < .001) and (aOR: 0.42, 95% C.I. 0.201,0.890, p = .023). Taking analgesics before vaccination decreased the likelihood of adverse reactions (aOR: 0.28, 95% C.I. 0.185,0.427, p < .001). High prevalence of adverse reactions was found among the healthcare workers, however short-lived. The most reported systemic adverse reactions were general body weakness, headache, and fever. We recommend intensification of campaigns on COVID-19 vaccines and their associated adverse effects to avoid the negative implication on uptake among the healthcare workers and the general population. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.relation.ispartofseries | Vol. 17;No. 11 | - |
dc.subject | COVID-19 | en_US |
dc.subject | COVID-19 vaccine | en_US |
dc.subject | Adverse reactions | en_US |
dc.subject | Symptoms | en_US |
dc.title | NON-LIFE-THREATENING ADVERSE REACTIONS FROM COVID-19 VACCINE; A CROSS-SECTIONAL STUDY WITH SELF-REPORTED SYMPTOMS AMONG GHANAIAN HEALTHCARE WORKERS | en_US |
dc.type | Article | en_US |
Appears in Collections: | School of Allied Health Sciences |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
NON-LIFE-THREATENING ADVERSE REACTIONS FROM COVID-19 VACCINE; A CROSS-SECTIONAL STUDY WITH SELF-REPORTED SYMPTOMS AMONG GHANAIAN HEALTHCARE WORKERS.pdf | 407.51 kB | Adobe PDF | View/Open |
Items in UDSspace are protected by copyright, with all rights reserved, unless otherwise indicated.